Ludivine S. Breger
Affiliations: | Lund University, Lund, Skåne län, Sweden |
Area:
Parkinson, animal model, a-syn, viral vectorGoogle:
"Ludivine Breger"Mean distance: 14.8 (cluster 11) | S | N | B | C | P |
Parents
Sign in to add mentorStephen B. Dunnett | grad student | 2010-2013 | Cardiff University | |
(second superviser) | ||||
Emma L. Lane | grad student | 2010-2013 | Cardiff University | |
(Main superviser) | ||||
Anders Björklund | post-doc | 2015- | Lund University | |
Cecilia Lundberg | post-doc | 2013-2015 | Wallenberg Neuroscience Center, Lund University |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Hoban DB, Shrigley S, Mattsson B, et al. (2020) Impact of α-synuclein pathology on transplanted hESC-derived dopaminergic neurons in a humanized α-synuclein rat model of PD. Proceedings of the National Academy of Sciences of the United States of America |
Quintino L, Avallone M, Brännstrom E, et al. (2018) GDNF-mediated rescue of the nigrostriatal system depends on the degree of degeneration. Gene Therapy |
Quintino L, Namislo A, Davidsson M, et al. (2018) Destabilizing Domains Enable Long-Term and Inert Regulation of GDNF Expression in the Brain. Molecular Therapy. Methods & Clinical Development. 11: 29-39 |
Fieblinger T, Zanetti L, Sebastianutto I, et al. (2018) Striatonigral neurons divide into two distinct morphological-physiological phenotypes after chronic L-DOPA treatment in parkinsonian rats. Scientific Reports. 8: 10068 |
Thakur P, Breger LS, Lundblad M, et al. (2017) Modeling Parkinson's disease pathology by combination of fibril seeds and α-synuclein overexpression in the rat brain. Proceedings of the National Academy of Sciences of the United States of America |
Breger LS, Kienle K, Smith GA, et al. (2016) Influence of chronic L-DOPA treatment on immune response following allogeneic and xenogeneic graft in a rat model of Parkinson's disease. Brain, Behavior, and Immunity |
Chtarto A, Humbert-Claude M, Bockstael O, et al. (2016) A regulatable AAV vector mediating GDNF biological effects at clinically-approved sub-antimicrobial doxycycline doses. Molecular Therapy. Methods & Clinical Development. 5: 16027 |
Breger L, Wettergren EE, Quintino L, et al. (2016) Regulated Gene Therapy. Methods in Molecular Biology (Clifton, N.J.). 1382: 57-66 |
Humbert-Claude M, Chtarto A, Bockstael O, et al. (2015) Toward the Pharmacological Control of Gene Transfer-Mediated Intracerebral Neurotrophic Factor Administration Journal of Neurological Surgery Part a: Central European Neurosurgery. 76 |
Breger LS, Lane EL. (2013) L-DOPA and graft-induced dyskinesia: different treatment, same story? Experimental Biology and Medicine (Maywood, N.J.). 238: 725-32 |